Discover open access scientific publications

Search, annotate, share and cite publications

Publications by B A Gordon

Deficiency of the Hexosaminidase a Activator Protein in a Case of GM2 Gangliosidosis; Variant AB

Pediatric Research

English

Related publications

Partial Deficiency of Beta-Hexosaminidase Activity in Canine GM2-gangliosidosis.

Tohoku Journal of Experimental Medicine

English

GM2-Gangliosidosis, AB Variant: Clinical, Ophthalmological, MRI, and Molecular Findings

English

Biochemical Characterization of the GM2 Gangliosidosis B1 Variant

Brazilian Journal of Medical and Biological Research

English

711. Intravenous Neonatal Gene Therapy Corrects GM2 Gangliosidosis in Sandhoff Mice for Long-Term, by Using AAV Viral Vector Expressing a New Hexosaminidase Variant

English

Clinical, Enzymatic, and Molecular Characterisation of a Portuguese Family With a Chronic Form of GM2-gangliosidosis B1 Variant.

Journal of Medical Genetics

Genetics

1996

English

Complete Localization of Disulfide Bonds in GM2 Activator Protein

English

The Possible Contribution of a General Glycosphingolipid Transporter, GM2 Activator Protein, to Atherosclerosis

Journal of Atherosclerosis and Thrombosis

Biochemistry

Internal Medicine

Cardiovascular Medicine

Cardiology

2006

English

Immunological Evidence for Deficiency in an Activator Protein for Sulfatide Sulfatase in a Variant Form of Metachromatic Leukodystrophy.

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

1983

English

377. Significant Therapeutic Benefit After Post-Symptomatic Gene Therapy in a Feline Model of GM2 Gangliosidosis

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by B A Gordon

Deficiency of the Hexosaminidase a Activator Protein in a Case of GM2 Gangliosidosis; Variant AB

Related publications

Partial Deficiency of Beta-Hexosaminidase Activity in Canine GM2-gangliosidosis.

GM2-Gangliosidosis, AB Variant: Clinical, Ophthalmological, MRI, and Molecular Findings

Biochemical Characterization of the GM2 Gangliosidosis B1 Variant

711. Intravenous Neonatal Gene Therapy Corrects GM2 Gangliosidosis in Sandhoff Mice for Long-Term, by Using AAV Viral Vector Expressing a New Hexosaminidase Variant

Clinical, Enzymatic, and Molecular Characterisation of a Portuguese Family With a Chronic Form of GM2-gangliosidosis B1 Variant.

Complete Localization of Disulfide Bonds in GM2 Activator Protein

The Possible Contribution of a General Glycosphingolipid Transporter, GM2 Activator Protein, to Atherosclerosis

Immunological Evidence for Deficiency in an Activator Protein for Sulfatide Sulfatase in a Variant Form of Metachromatic Leukodystrophy.

377. Significant Therapeutic Benefit After Post-Symptomatic Gene Therapy in a Feline Model of GM2 Gangliosidosis